Regulatory Affairs Professionals Society

Experts weigh in on FDA’s transparency roadmap

The US Food and Drug Administration (FDA) recently released a transparency roadmap outlining its achievements in FY 2026 and ...
Los Angeles Times

FDA’s new expert panels are rife with financial conflicts and fringe views

New advisors to the Food and Drug Administration on antidepressants, menopause drugs and other topics have conflicts of interest and contrarian views. Nearly 80 researchers sent a letter to the FDA ...
FiercePharma

FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks

The FDA’s director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon leave the agency after seven years. (Sarah Silbiger/Stringer/Getty Images News) The FDA’s ...
Healio

Editorial: Why the FDA’s move away from animal testing is scientifically necessary

Please provide your email address to receive an email when new articles are posted on . The FDA has pledged to reduce animal testing for monoclonal antibodies. The decision reflects longstanding ...
Food Safety News

User fees from food companies could support FDA’s food safety programs

If the FDA charged food companies user fees it could strengthen its oversight of food safety, according to a recent study. The study, “Advancing the FDA’s Human Foods Program Through Additional ...
Scripps News on MSN

FDA's ongoing review of abortion pill frustrates anti-abortion advocates

FDA's ongoing review of abortion pill frustrates anti-abortion advocates ...
RAPS

FDA’s device center releases guidance agenda for FY 2027

Finalizing guidance on artificial intelligence-enabled devices throughout their product lifecycle and on pre-determined change control plans (PCCPs) tops the to-do list for the US Food and Drug ...